Veracyte Announces Release Date for Q2 2024 Financial Results
2 Sources
2 Sources
[1]
Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024 By Investing.com
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the second quarter of 2024 after the close of market on Tuesday, August 6, 2024. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. The conference call will be webcast live from the company's website and will be available via the following link: https://edge.media-server.com/mmc/p/p5tuszv4. A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company's website at https://investor.veracyte.com/events-presentations. The conference call dial-ins can be accessed by registering at: https://register.vevent.com/register/BIbb7f6b70b4ce4820b6391059390d6139 About Veracyte (NASDAQ:VCYT) Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit www.veracyte.com or follow us on LinkedIn or X (Twitter).
[2]
Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024
Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the second quarter of 2024 after the close of market on Tuesday, August 6, 2024. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. The conference call will be webcast live from the company's website and will be available via the following link: https://edge.media-server.com/mmc/p/p5tuszv4. A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company's website at https://investor.veracyte.com/events-presentations. The conference call dial-ins can be accessed by registering at: https://register.vevent.com/register/BIbb7f6b70b4ce4820b6391059390d6139 About Veracyte Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit www.veracyte.com or follow us on LinkedIn or X (Twitter).
Share
Share
Copy Link
Veracyte, Inc., a leading genomic diagnostics company, has scheduled the release of its second quarter 2024 financial results for August 6, 2024, after the close of the U.S. stock market. The company will also host a conference call to discuss the results and provide a business update.
Veracyte Sets Date for Q2 2024 Financial Disclosure
Veracyte, Inc. (Nasdaq: VCYT), a prominent player in the genomic diagnostics sector, has announced its plans to release the financial results for the second quarter of 2024. The company will unveil these results on Tuesday, August 6, 2024, after the U.S. stock market closes
1
.Conference Call and Webcast Details
Following the release of the financial results, Veracyte will host a conference call and webcast at 4:30 p.m. Eastern Time on the same day. This event will provide an opportunity for investors and interested parties to gain insights into the company's performance and future outlook
2
.Accessing the Conference Call
For those wishing to participate in the conference call, the following details have been provided:
- Dial-in number (U.S.): (877) 344-7529
- Dial-in number (International): (412) 317-0088
- Conference ID: 2265536
It's important to note that participants should dial in at least 5-10 minutes prior to the start of the call to ensure timely access
1
.Webcast Information
For those preferring to listen via the internet, a live webcast of the presentation will be available on Veracyte's website. Interested parties can access this webcast through the Investor Relations section of the company's website at http://investor.veracyte.com
2
.Related Stories
Replay Availability
Understanding that not all interested parties may be able to join the live call, Veracyte has made provisions for a replay. The conference call will be available for replay through August 13, 2024. To access the replay, participants can use the following methods:
- Dial-in number (U.S.): (877) 344-7529
- Dial-in number (International): (412) 317-0088
- Conference ID: 2265536
Additionally, the webcast will be archived on Veracyte's website for 90 days following the completion of the call
1
2
.About Veracyte
Veracyte, Inc. is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions. The company's growing menu of advanced diagnostic tests help patients avoid risky, costly procedures and interventions, and reduce time to appropriate treatment
2
.References
Summarized by
Navi
[1]
[2]
Related Stories
Weekly Highlights
1
Anthropic Secures $13B in Funding, Reaching $183B Valuation Amid AI Industry Boom
Business and Economy
2
OpenAI Partners with Broadcom to Develop Custom AI Chips, Challenging Nvidia's Dominance
Technology
3
Tesla Proposes $1 Trillion Pay Package for Elon Musk, Tied to Ambitious AI and Robotics Goals
Business and Economy
Weekly Highlights
Explore today's top stories
Your Daily Dose of Curated AI News
Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Spend less time searching for the latest in AI and get straight to action.
